Related Experiment Video
Updated: Jun 2, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Beyond Pneumonia: Autoimmune Pulmonary Alveolar Proteinosis in a Pediatric Patient
Jessica Satei1, Tarek Husien1, Ibrahim Abdulhamid2
1Pediatrics, Detroit Medical Center (DMC) Children's Hospital of Michigan, Detroit, USA.
Abstract:
Pulmonary alveolar proteinosis (PAP) is a rare pediatric lung disorder marked by the accumulation of surfactant-like material within the alveoli, impairing normal gas exchange. Among its subtypes, the autoimmune form, caused by neutralizing antibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF), is particularly uncommon in children and often mimics atypical infections. We describe the case of a 12-year-old girl with progressive dyspnea, hypoxia, and declining physical performance over four months. Imaging revealed diffuse bilateral ground-glass opacities, and initial treatment for atypical pneumonia showed minimal improvement. Further workup, including bronchoalveolar lavage and lung biopsy, identified alveolar spaces filled with periodic acid-Schiff (PAS)-positive proteinaceous material. Serologic testing confirmed elevated GM-CSF autoantibodies, establishing the diagnosis of autoimmune PAP. The patient required supplemental oxygen and underwent multiple whole lung lavages (WLL), ultimately achieving significant clinical improvement and functional recovery. This case underscores the importance of considering autoimmune PAP in pediatric patients with unexplained interstitial lung disease unresponsive to conventional therapy. Early testing for GM-CSF autoantibodies and timely initiation of WLL may prevent misdiagnosis and lead to favorable outcomes.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Chronic Obstructive Pulmonary Disease II: Emphysema